FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Sunday, June 3, 2018
FDA wants to shorten new drug monopolies to cut costs
FDA wants to shorten new drug monopolies to cut costs
The U.S. Food and Drug Administration chief has made a commitment to speeding up approvals of cheap generic medicines.
Related Posts:
In Chinese border city, locals hope North Korea opens up- 3 Ways to Boost Your Retirement Savings As You Get Older
- Should Investors "Buy, Sell, or Hold" These Futuristic Ideas?
- Have a Side Hustle? Here's What You Need to Know About Filing Your Taxes
- Bayer faces second trial over alleged Roundup cancer risk
0 comments:
Post a Comment